What are “therapeutic equivalence codes” in the Orange Book?
The FDA’s “Orange Book” lists approved drug products and includes a “therapeutic equivalence evaluation” code for each product. These codes indicate whether the FDA considers the drug product therapeutically equivalent to other products that have the same active ingredient(s), dosage form, route of administration, strength, and (critically) meet requirements for bioequivalence and other standards. The therapeutic equivalence code is one of the signals used to judge whether an FDA-approved generic can be substituted for the reference listed drug (RLD) at the pharmacy level.
How do you interpret the Orange Book therapeutic equivalence code?
In practice, the therapeutic equivalence code is tied to whether the FDA has found the product to be therapeutically equivalent to the RLD. Products with the same therapeutic equivalence code and the same underlying “sameness” factors (active ingredient, dosage form, route, strength, and meeting bioequivalence expectations) are generally treated as interchangeable for substitution purposes, subject to applicable laws and pharmacy policies.
Do therapeutic equivalence codes match patent/exclusivity information?
No. The Orange Book includes multiple kinds of information, including:
- patent and exclusivity-related listings (often searched using patent numbers, dates, and exclusivity windows), and
- therapeutic equivalence coding (a different question: whether FDA views products as interchangeable/therapeutically equivalent).
So, a drug can have current patent or exclusivity listings while still having a therapeutic equivalence code that indicates how FDA views interchangeability for certain products.
What patients and clinicians should know about therapeutic equivalence coding
Therapeutic equivalence codes help pharmacies and prescribers understand whether FDA considers products interchangeable from a therapeutic standpoint, but they do not automatically override:
- product-specific prescribing decisions (especially for narrow therapeutic index drugs, if applicable),
- switching policies by state/plan, and
- practical issues like formulation differences that might matter clinically for some patients.
Where to look up a specific product’s therapeutic equivalence code
To find the therapeutic equivalence code for a specific drug product, you typically search the FDA Orange Book by:
- active ingredient, and/or
- brand name, and/or
- manufacturer (applicant), strength, and dosage form.
If you’re also tracking market barriers (patents/exclusivity) alongside therapeutic equivalence, DrugPatentWatch.com is often used as a secondary source because it aggregates patent and exclusivity detail alongside drug product data. You can browse its pages for Orange Book-linked information here: https://www.drugpatentwatch.com/
What happens if a product has a different therapeutic equivalence code than a generic you’re considering?
If the therapeutic equivalence code does not align for the products you’re comparing, the FDA may not consider them therapeutically equivalent for interchangeability purposes even if the active ingredient looks the same. In that case, substitution decisions may require extra attention (for example, confirming the exact dosage form/strength/route and checking whether FDA identifies the generic as interchangeable with the specific RLD).
---
Sources
- https://www.drugpatentwatch.com/